Cellular uptake and transport of gold nanoparticles incorporated in a liposomal carrier

Nanomedicine. 2010 Feb;6(1):161-9. doi: 10.1016/j.nano.2009.04.009. Epub 2009 May 15.

Abstract

Recent interest in using gold nanoparticles (Au NPs) for therapy in radiation medicine has motivated development of a liposome-based system to enhance their delivery to cells. In this study, liposomes were demonstrated to perform like a "Trojan Horse" to deliver small (1.4 nm) Au NPs into tumor cells by overcoming the energetically unfavorable endocytosis process for small NPs. The results reveal that the liposomal approach provides a thousand-fold enhancement in the cellular uptake of the small Au NPs. Real-time intracellular tracking of the Au NP-liposomes revealed an average speed of 12.48 +/- 3.12 microm/hr for their intracellular transport. Analysis of the time-dependent intracellular spatial distribution of the Au NP-liposomes demonstrated that they reside in lysosomes (final degrading organelles) within 40 minutes of incubation. Knowledge gained in these studies opens the door to pursuing liposomes as a viable strategy for delivery of Au NPs in radiation therapy applications.

From the clinical editor: Gold nanoparticles (Au NPs) as part of an optimized liposome-based delivery system have been proposed for therapy in radiation medicine. The approach resulted in a thousand-fold enhancement in the cellular uptake of Au NPs compared to conventional delivery methods, with the nanoparticles residing in lysosomes within 40 minutes of incubation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport
  • Drug Carriers / chemistry*
  • Endocytosis
  • Endosomes / metabolism
  • Gold / metabolism*
  • HeLa Cells
  • Humans
  • Intracellular Space / metabolism
  • Liposomes
  • Lysosomes / metabolism
  • Metal Nanoparticles / analysis*
  • Metal Nanoparticles / ultrastructure
  • Spectrometry, X-Ray Emission

Substances

  • Drug Carriers
  • Liposomes
  • Gold